These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15999694)

  • 21. [Glucokinase knockout mice].
    Terauchi Y; Kadowaki T
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():746-52. PubMed ID: 9513507
    [No Abstract]   [Full Text] [Related]  

  • 22. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth.
    Kitamura T; Nakae J; Kitamura Y; Kido Y; Biggs WH; Wright CV; White MF; Arden KC; Accili D
    J Clin Invest; 2002 Dec; 110(12):1839-47. PubMed ID: 12488434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 and identification of insulin receptor substrate-2.
    Kadowaki T; Tamemoto H; Tobe K; Terauchi Y; Ueki K; Kaburagi Y; Yamauchi T; Satoh S; Sekihara H; Aizawa S; Yazaki Y
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S103-8. PubMed ID: 8894493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Insulin signaling and pathophysiology of type 2 diabetes mellitus].
    Ogawa W; Kasuga M
    Nihon Rinsho; 2006 Jul; 64(7):1381-9. PubMed ID: 16838661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What have we learned thanks to genetics in type II diabetes and its complications?].
    Froguel P
    Nephrologie; 1999; 20(2):59-63. PubMed ID: 10227025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice.
    Cantley J; Choudhury AI; Asare-Anane H; Selman C; Lingard S; Heffron H; Herrera P; Persaud SJ; Withers DJ
    Diabetologia; 2007 Jun; 50(6):1248-56. PubMed ID: 17393136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversible gene knockdown in mice using a tight, inducible shRNA expression system.
    Seibler J; Kleinridders A; Küter-Luks B; Niehaves S; Brüning JC; Schwenk F
    Nucleic Acids Res; 2007; 35(7):e54. PubMed ID: 17376804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perspective: The insulin signaling system--a common link in the pathogenesis of type 2 diabetes.
    Withers DJ; White M
    Endocrinology; 2000 Jun; 141(6):1917-21. PubMed ID: 10830270
    [No Abstract]   [Full Text] [Related]  

  • 29. [Insulin resistance in type 2 diabetes as a microdomain syndrome].
    Inokuchi JI; Igarashi Y
    Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1179-83. PubMed ID: 12807027
    [No Abstract]   [Full Text] [Related]  

  • 30. Mouse models created to study the pathophysiology of Type 2 diabetes.
    LeRoith D; Gavrilova O
    Int J Biochem Cell Biol; 2006; 38(5-6):904-12. PubMed ID: 16103004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice.
    Kulkarni RN; Almind K; Goren HJ; Winnay JN; Ueki K; Okada T; Kahn CR
    Diabetes; 2003 Jun; 52(6):1528-34. PubMed ID: 12765966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes.
    Mauvais-Jarvis F; Ueki K; Fruman DA; Hirshman MF; Sakamoto K; Goodyear LJ; Iannacone M; Accili D; Cantley LC; Kahn CR
    J Clin Invest; 2002 Jan; 109(1):141-9. PubMed ID: 11781359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypes of IRS-2 deficient mice produced by reproductive technology are stable.
    Hashimoto H; Arai T; Ohnishi Y; Eto T; Ito M; Hioki K; Suzuki R; Yamauchi T; Ohsugi M; Saito M; Ueyama Y; Tobe K; Kadowaki T; Tamaoki N; Kosaka K
    Exp Anim; 2007 Apr; 56(2):149-54. PubMed ID: 17460360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1.
    Abe H; Yamada N; Kamata K; Kuwaki T; Shimada M; Osuga J; Shionoiri F; Yahagi N; Kadowaki T; Tamemoto H; Ishibashi S; Yazaki Y; Makuuchi M
    J Clin Invest; 1998 Apr; 101(8):1784-8. PubMed ID: 9541510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetically engineered mice as animal models for NIDDM.
    Joshi RL; Lamothe B; Bucchini D; Jami J
    FEBS Lett; 1997 Jan; 401(2-3):99-103. PubMed ID: 9013866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue-specific targeting of the insulin receptor gene.
    Kulkarni RN; Okada T
    Endocrine; 2002 Dec; 19(3):257-66. PubMed ID: 12624425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular pathogenesis of type 2 diabetes mellitus].
    Kadowaki T
    Seikagaku; 1999 Nov; 71(11):1281-98. PubMed ID: 10614177
    [No Abstract]   [Full Text] [Related]  

  • 38. Diabetes outfoxed by GLP-1?
    Holz GG; Chepurny OG
    Sci STKE; 2005 Jan; 2005(268):pe2. PubMed ID: 15671479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of caloric restriction on insulin pathway gene expression in the skeletal muscle and liver of normal and long-lived GHR-KO mice.
    Masternak MM; Al-Regaiey KA; Del Rosario Lim MM; Jimenez-Ortega V; Panici JA; Bonkowski MS; Bartke A
    Exp Gerontol; 2005; 40(8-9):679-84. PubMed ID: 16054319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular basis for the development of type 2 diabetes mellitus].
    Kasuga M
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():468-76. PubMed ID: 12238086
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.